Tailin [SZSE:300813] organizes that workflow through specialized cell and gene therapy solutions built around aseptic preparation, controlled cell culture and live-cell monitoring. Its CGT-focused equipment includes a fully enclosed cell and gene therapy isolator, a honeycomb cell culture system and a live cell imaging system. Together, they address three parts of the same operating problem: keeping the process sterile, giving cells the right culture environment and allowing teams to monitor growth without unnecessary disturbance.
That combination makes Tailin a Top Cell and Gene Therapy Solutions provider. The company’s value is not in a single machine placed inside a laboratory. It lies in how its equipment supports the sequence of cell therapy work, from preparation and quality control to culture expansion and observation.
Aseptic Control Comes First
Cell therapy manufacturing begins with control over the operating environment. Before expansion or monitoring can begin, operators need a protected space where cell products can be handled with reduced contamination risk. This is where the isolator becomes the anchor of Tailin’s CGT offering. The company’s cell and gene therapy isolator is designed as a fully enclosed, integrated operating system for cell product preparation. It supports work such as separation, activation, modification, expansion, observation, collection and dispensing within a continuous sterile environment. For teams working in GMP sterile production, that enclosure changes the logic of the workspace. The process gains a controlled barrier around the cell product itself, beyond what the surrounding cleanroom alone provides.
The isolator provides a Class A clean environment and integrates vaporized hydrogen peroxide sterilization. It also supports real-time recording of system control and environmental monitoring data, operation video storage and traceability across production activity. These details matter because cell therapy teams need documented evidence of how that process was controlled.
Cell and gene therapy solutions must protect living material while keeping the process visible, traceable and controlled.
Aseptic control functions as the first condition that allows the rest of the workflow to proceed with confidence.
From Handling to Culture
Once cells are prepared, the workflow moves into a different kind of discipline. Culture conditions must remain stable, repeatable and appropriate for cell growth. Temperature, humidity, oxygen concentration and carbon dioxide concentration are managed as active production variables throughout culture.
This stage is important because cells respond actively to their environment throughout culture. Changes in gas concentration, humidity, temperature or handling can affect how the process behaves. A system built for continuous aseptic culture gives teams a way to manage expansion while maintaining environmental control.
For cell and gene therapy organizations, that flexibility matters because different projects often require different sample volumes, culture durations or process conditions. A cultivation platform that supports multiple samples and scale helps teams move from preparation into expansion without treating culture as a disconnected laboratory step.
Observation Without Disturbance
Monitoring cell growth has another challenge. Teams need visibility, but each intervention can disturb the culture environment. Entering a cleanroom, opening an incubator, moving vessels or staining cells can add handling steps that researchers and production teams may prefer to avoid. Tailin addresses that through live-cell imaging systems designed for use inside incubators. The CellScan and Cytoimage platforms enable real-time, quantifiable live-cell imaging and analysis. Users can set custom projects, run periodic scans, calculate cell numbers and determine confluence while cell growth data is saved to the cloud.
The real value is that observation can happen closer to the culture environment. Researchers can monitor cell status remotely without repeatedly entering the cleanroom. The system remains inside the incubator for direct observation, reducing interference linked to temperature fluctuation, medium disturbance and contamination risk.
Label-free imaging adds another layer of protection. Because cells do not need to be stained for direct status acquisition, teams can gather visual and quantitative information while reducing unnecessary manipulation. In a CGT workflow, that kind of monitoring fits the broader requirement to protect both the process and the product.
Traceability and a Connected Platform
Cell and gene therapy work extends past technical execution; the process must be documented. Environmental conditions, operator activity, system controls, culture status and monitoring data all feed into the record that proves how the process was run.
Tailin’s equipment set brings traceability into multiple stages of the workflow. The isolator records system control and environmental monitoring data, stores operation video and supports production-operation traceability. The honeycomb culture system records and stores system and environmental data across the production and culture process. The live-cell imaging system adds cell growth data, imaging records, cell-number calculation and confluence measurement.
-
Tailin’s CGT strength lies in connecting aseptic preparation, controlled culture and real-time observation into one practical workflow.
For CGT teams, that level of detail turns a sterile workspace into one they can trust. Complete, connected records make it easier to interpret a problem in cell preparation, culture or monitoring, and to pinpoint when it occurred.
Authority management and cloud-linked data give teams organized, permission-based access to that information. As CGT work moves between research, clinical preparation and manufacturing environments, teams need systems that help maintain discipline around who operates equipment, who reviews data and how process records are retained.
A Platform Built Around CGT Work
Tailin’s strongest positioning comes from the way its CGT equipment addresses the workflow as a connected sequence. The isolator protects the preparation and aseptic handling. The honeycomb culture system manages cultivation under controlled conditions. The live-cell imaging system adds observation and quantitative monitoring without forcing repeated disruption of the culture environment.
That sequence is important. Cell and gene therapy organizations cannot treat sterility, culture and monitoring as separate concerns. A strong process depends on the relationship between them. Cells prepared under controlled conditions still need stable expansion. Cultures grown under stable conditions still need observation. Monitoring is more useful when it connects back to traceable process records.
The company’s equipment is especially relevant for cell therapy manufacturing, GMP sterile laboratories and clinical or research centers where aseptic control and process visibility are central to daily work. It does not promise a simplified path to therapy success. It gives these teams the infrastructure to handle living cell products more carefully and consistently.
Tailin stands out by focusing on the environments where CGT’s work is most vulnerable. Its solutions protect sterile preparation, maintain controlled culture and make cell growth easier to observe. In a field where the product can be affected by every step around it, operating discipline matters.


![Tailin [SZSE:300813] Tailin [SZSE:300813]](/company_logos/Untitled-7-0zhb5.jpg)